NasdaqCM - Delayed Quote USD

Qualigen Therapeutics, Inc. (QLGN)

0.3150 +0.0228 (+7.80%)
At close: April 23 at 4:00 PM EDT
0.3201 +0.01 (+1.62%)
Pre-Market: 8:54 AM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-10,304.2630
-10,304.2630
-13,247.5410
-14,730.7420
Investing Cash Flow
4,215.9430
4,215.9430
-183.7630
-141.3640
Financing Cash Flow
-550.0000
-550.0000
2,910.5150
8,433.8080
End Cash Position
401.8030
401.8030
3,165.9850
17,538.2720
Income Tax Paid Supplemental Data
5.5710
5.5710
5.5710
5.1330
Interest Paid Supplemental Data
--
--
--
1.2330
Capital Expenditure
--
--
-319.1170
-141.3640
Issuance of Capital Stock
--
--
--
8,820.0000
Issuance of Debt
--
--
2,903.8470
--
Repayment of Debt
-550.0000
-550.0000
--
-138.7390
Repurchase of Capital Stock
--
--
-0.5050
--
Free Cash Flow
-10,304.2630
-10,304.2630
-13,247.5410
-14,872.1060
12/31/2021 - 6/23/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers